{"id":46094,"date":"2022-07-12T23:01:32","date_gmt":"2022-07-12T21:01:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/"},"modified":"2022-07-12T23:01:32","modified_gmt":"2022-07-12T21:01:32","slug":"agilon-health-sets-date-to-report-second-quarter-2022-financial-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/","title":{"rendered":"agilon health Sets Date to Report Second Quarter 2022 Financial Results"},"content":{"rendered":"<div>\n<p>AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to discuss the results.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/5\/Agilon_Logo_640x360.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg\"><\/a><\/p>\n<p>\nThe conference call can be accessed by dialing (844) 200-6205 for U.S. participants and +1 (646) 904-5544 for international participants and referencing participant code 043762. A simultaneous webcast can be accessed by visiting the \u201cEvents &amp; Presentations\u201d section of agilon\u2019s Investor Relations website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.agilonhealth.com&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.agilonhealth.com&amp;index=1&amp;md5=ed8506bdf498b341d11143e62df66d26\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/investors.agilonhealth.com<\/a>. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.\n<\/p>\n<p>\n<b>About agilon health<\/b>\n<\/p>\n<p>\nagilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups transition to a value-based Total Care Model for senior patients. agilon provides the technology, people, capital, process, and access to a peer network that allow physician groups to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need \u2013 one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 17 diverse communities and is here to help more of our nation&#8217;s leading physician groups and health systems have a sustained, thriving future. For more information about agilon health, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.agilonhealth.com&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=www.agilonhealth.com&amp;index=2&amp;md5=19b3f6015c8a2a707c17dfd8f6a30c04\" rel=\"nofollow noopener\" shape=\"rect\">www.agilonhealth.com<\/a> and connect with us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fagilonhealth%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Eauthor&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=Twitter&amp;index=3&amp;md5=ab28a223cb478e4bfc26187137152999\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fagilonhealth%2F&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=Instagram&amp;index=4&amp;md5=5b4add73cd4672f51bcf4bd4a1b8ccc2\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fagilonhealth%2F&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=cd7f2fba329e48e93aeefcbbcf033ad7\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCMf96WOxRDTqj1n9GsUvDcA&amp;esheet=52778611&amp;newsitemid=20220712005763&amp;lan=en-US&amp;anchor=YouTube&amp;index=6&amp;md5=134acc78daefa0f2eb1393ada9840fac\" rel=\"nofollow noopener\" shape=\"rect\">YouTube<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact<\/b><br \/>Matthew Gillmor<br \/>\n<br \/>VP, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x69;&#x6e;&#x76;e&#115;&#x74;&#x6f;&#x72;s&#64;&#x61;&#x67;&#x69;l&#111;&#x6e;&#x68;&#x65;a&#108;&#x74;&#x68;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">i&#110;&#118;&#x65;&#x73;to&#114;&#115;&#x40;&#x61;gi&#108;&#111;&#x6e;&#x68;ea&#108;&#x74;&#x68;&#x2e;c&#111;&#109;<\/a>\n<\/p>\n<p>\n<b>Media Contact<\/b><br \/>Adrienne Yi<br \/>\n<br \/>Sr. Director, Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x6d;&#x65;d&#x69;&#97;&#64;&#x61;&#103;&#x69;&#108;o&#x6e;&#104;e&#x61;&#108;&#x74;&#104;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;e&#x64;&#105;&#x61;&#64;a&#x67;&#105;&#x6c;&#111;n&#x68;&#101;&#x61;&#108;t&#x68;&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46094","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-12T21:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"agilon health Sets Date to Report Second Quarter 2022 Financial Results\",\"datePublished\":\"2022-07-12T21:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/\"},\"wordCount\":309,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005763\\\/en\\\/1220694\\\/21\\\/Agilon_Logo_640x360.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/\",\"name\":\"agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005763\\\/en\\\/1220694\\\/21\\\/Agilon_Logo_640x360.jpg\",\"datePublished\":\"2022-07-12T21:01:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005763\\\/en\\\/1220694\\\/21\\\/Agilon_Logo_640x360.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005763\\\/en\\\/1220694\\\/21\\\/Agilon_Logo_640x360.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"agilon health Sets Date to Report Second Quarter 2022 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend","og_description":"AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-12T21:01:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"agilon health Sets Date to Report Second Quarter 2022 Financial Results","datePublished":"2022-07-12T21:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/"},"wordCount":309,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/","url":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/","name":"agilon health Sets Date to Report Second Quarter 2022 Financial Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg","datePublished":"2022-07-12T21:01:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220712005763\/en\/1220694\/21\/Agilon_Logo_640x360.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/agilon-health-sets-date-to-report-second-quarter-2022-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"agilon health Sets Date to Report Second Quarter 2022 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46094"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46094\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}